Inhaled Corticosteroids and the Risk of Lung Cancer in Chronic Obstructive Pulmonary Disease Patients: A Systematic Review and Meta-Analysis.

Amare Abera TarekeWondwosen DebebeAddis Alem Nebiyou Simegnew Bayileyegn Taddese Alemu ZerfuAndualem Mossie Ayana

Published in: Pulmonary medicine (2022)

The use of ICS in COPD patients reduces the risk of lung cancer. The risk reduction was independent of smoking status and latency period. Future studies should focus on the optimum dose and controlling confounders like asthma.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
chronic obstructive pulmonary disease
cystic fibrosis
patient reported outcomes
allergic rhinitis